Cargando…

Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study

OBJECTIVE: Several studies have reported that the controlling nutritional status (CONUT) score is a prognostic predictor for survival among patients with different types of cancer. We assessed the prognostic value of changes in the CONUT score during treatment and the ΔCONUT-EBV DNA score in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Hui, Guo, Shanshan, Liu, Liting, Chen, Qiuyan, Liang, Yujing, Liu, Sailan, Sun, Xuesong, Tang, Qingnan, Li, Xiaoyun, Guo, Ling, Mo, Haoyuan, Tang, Linquan, Mai, Haiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088186/ https://www.ncbi.nlm.nih.gov/pubmed/34132505 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0627

Ejemplares similares

Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection
por: Li, Xiaoyun, et al.
Publicado: (2020)

EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma
por: Yuan, Li, et al.
Publicado: (2022)

Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [(18)F]FDG PET/CT parameters
por: Dongxiang, Wen, et al.
Publicado: (2022)

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study
por: Chen, Qiuyan, et al.
Publicado: (2018)

Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma
por: Wu, Zhen, et al.
Publicado: (2022)

Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma
por: Guo, Shan-Shan, et al.
Publicado: (2022)

Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies
por: Li, Chaofeng, et al.
Publicado: (2018)

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
por: Liu, Li-Ting, et al.
Publicado: (2019)

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
por: Yang, Jin-Hao, et al.
Publicado: (2021)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
por: Ahmed, Naveed, et al.
Publicado: (2022)

Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma
por: Yu, Justin, et al.
Publicado: (2021)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis
por: Liu, Weixing, et al.
Publicado: (2021)

Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma
por: Liu, Li-Ting, et al.
Publicado: (2021)

EBV based cancer prevention and therapy in nasopharyngeal carcinoma
por: Cao, Ya
Publicado: (2017)

Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
por: Wang, Hong-Bo, et al.
Publicado: (2015)

The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection
por: Guo, Can, et al.
Publicado: (2006)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
por: Ye, Qian, et al.
Publicado: (2021)

Nasopharyngeal carcinoma: an EBV-associated tumour not significantly influenced by HIV-induced immunosuppression. The AIDS/Cancer Working Group.
por: Melbye, M., et al.
Publicado: (1996)

Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
por: Li, Jiang, et al.
Publicado: (2007)

Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer
por: Nilsson, Johan S., et al.
Publicado: (2019)

EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
por: Yang, Tingting, et al.
Publicado: (2022)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma
por: Xie, Jiajun, et al.
Publicado: (2021)

Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
por: Zhu, Shanli, et al.
Publicado: (2020)

Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma
por: Du, Xiao-Jing, et al.
Publicado: (2016)

Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma
por: Wang, Zifeng, et al.
Publicado: (2016)

Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy
por: Tang, Ling-Long, et al.
Publicado: (2014)

Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?
por: Guo, Shan-Shan, et al.
Publicado: (2015)

Efficient Immortalization of Primary Nasopharyngeal Epithelial Cells for EBV Infection Study
por: Yip, Yim Ling, et al.
Publicado: (2013)

Monoamine oxidase A is down-regulated in EBV-associated nasopharyngeal carcinoma
por: Lee, Hui Min, et al.
Publicado: (2020)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
por: Zhou, Han, et al.
Publicado: (2020)

Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma
por: He, Jiang, et al.
Publicado: (2016)

Systematic comparison of plasma EBV DNA, anti‐EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma
por: Tan, Lu Ping, et al.
Publicado: (2019)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
por: Trinh, Cua Thi Hong, et al.
Publicado: (2023)

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
por: Kamara, Saidu, et al.
Publicado: (2023)

Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor
por: Guo, Jia, et al.
Publicado: (2023)

EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway
por: Zhou, Xiaohan, et al.
Publicado: (2019)

EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma
por: Boysen, T, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2jpru7o3ndgif7r1v3895g9p8s